News BioNTech SE

Equities

BNTX

US09075V1026

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
86.17 ^USD	-0.27%		-0.97%	-18.35%

Apr. 15	Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla...
Apr. 15	Market outlook is uncertain, but optimism prevails

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla...	Apr. 15
Market outlook is uncertain, but optimism prevails	Apr. 15
BioNTech : Invitation to the Annual General Meeting 2024 - Form 6-K	Apr. 08	PU
BioNTech SE Announces Three-Year Follow-Up Data from Phase 1 Trial with the mRNA-Based Individualized Neoantigen-Specific Immunotherapy Candidate Autogene Cevumeran	Apr. 08	CI
BioNTech Reports Positive 3-Year Data From Phase 1 Trial of Cevumeran in Pancreatic Cancer	Apr. 08	MT
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer	Apr. 07	AQ
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer	Apr. 07	GL
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher	Apr. 01	MT
UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating	Mar. 27	MT
WuXi Biologics Reports Solid 2023 Annual Results	Mar. 27	AQ
News Highlights : Top Company News of the Day - Tuesday at 7 AM ET	Mar. 26	DJ
European Midday Briefing : Investors Hold Back Ahead of Key Inflation Print	Mar. 26	DJ
News Highlights : Top Company News of the Day - Tuesday at 5 AM ET	Mar. 26	DJ
News Highlights : Top Company News of the Day - Tuesday at 3 AM ET	Mar. 26	DJ
BioNTech gets US agency notice over default on COVID vaccine royalties	Mar. 25	RE
Moderna, Inc. prepares for the post-Covid era	Mar. 25
BioNTech gets notice from US agency over default on COVID vaccine royalties	Mar. 25	RE
BioNTech gets notice from NIH on default on royalties	Mar. 25	RE
BioNTech SE Receives Notice of Default from the NIH	Mar. 25	CI
BioNTech : DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K - Form 6-K	Mar. 25	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BIONTECH : A miss is a miss

March 21, 2024 at 09:27 am EDT